NTLA is trading 4% up now at $17.93 after several sessions of steady gains. Recent upside follows earlier positive sentiment on its CRISPR pipeline and bullish analyst targets, but there is no fresh, company-specific news headline this morning clearly driving today’s move. With major U.S. indices also higher, NTLA’s advance appears aligned with ongoing momentum and broader risk-on sentiment rather than a new discrete catalyst.